J-pharma Co., Ltd.
Clinical trials sponsored by J-pharma Co., Ltd., explained in plain language.
-
New hope for bile duct cancer: experimental drug nanvuranlat in final testing
Disease control Recruiting nowThis phase 3 trial tests a new drug called nanvuranlat in 480 adults with advanced biliary tract cancer that has worsened after prior treatment. Participants receive either nanvuranlat or one of several standard treatments. The main goal is to see if nanvuranlat helps people live…
Phase: PHASE3 • Sponsor: J-Pharma Co., Ltd. • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New drug JPH034 enters first human safety tests
Knowledge-focused Recruiting nowThis early-stage study is testing whether a new drug, JPH034, is safe for people. About 40 healthy adults aged 18 to 50 will receive either the drug or a placebo. Researchers will monitor side effects and measure how the drug moves through the body. This study does not aim to tre…
Phase: PHASE1 • Sponsor: J-Pharma Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC